9th Annual Biomarkers Congress

Oncology: Food and Drug Administration

Total Score People Score Events Score
27 17 23
Date Event Presentation Speakers
May 31, 2013 ASCO Annual Meeting 2013 Career Choices: Options in Academia, Practice, Industry, and Government Richard Pazdur
May 28, 2013 NGS Translate Ensuring the Generation of High Quality NGS Data Weida Tong
April 6, 2013 AACR Annual Meetings Personalized Medicine in Clinical Trials: What You Need to Know Now Elizabeth Mansfield, U.S. Food and Drug Administration, Rockville, MD Elizabeth Mansfield
December 8, 2012 54th American Society of Haematology Annual Meeting and Exposition Career-Development Lunch Sessions Albert B. Deisseroth
May 10, 2011 5th Annual Conference in Japan for Asian New Drug Development Session Description | Ask the Asian Regulators Meir-Chyun Tzou
May 20, 2010 Antibody Optimization Trastuzumab Conjugate for the Treatment of Trastuzumab-Resistant Human Breast Cancer: Increasing Magnitude and Duration of Response Wen Jin Wu
May 4, 2010 Biomarker World Congress 2010 Biomarkers and the Development of Personalized Medicine: A Regulatory Perspective Francis Kalush
Role of Biomarkers in Drug Development: Application in Late Phase Clinical Trials Yaning Wang
February 22, 2010 2010 PERSONALIZED MEDICINE PARTNERSHIPS CONFERENCE FDA's Experience with Personalized Medicine Clearances & Approvals Elizabeth Mansfield
September 24, 2009 TRACK 1: Optimizing Clinical Trials : Third Annual clinical biomarkers The Potential Impact of Recently Approved and Emerging Molecular Diagnostics in Drug-Diagnostics Co-Development Francis Kalush
September 24, 2009 Track 2: Implementing Personalized Medicine : Inaugural Targeted Therapy The Potential Impact of Recently Approved and Emerging Molecular Diagnostics in Drug-Diagnostics Co-Development Francis Kalush
August 10, 2009 Second Annual Trends in Cancer Diagnostics Ensuring the Safety and Validity of Molecular Diagnostic Tests Alberto Gutierrez
June 9, 2009 Third Annual Cardiotoxicity and Drug Safety Improving Safety in Medical Products Wendy Sanhai
January 26, 2009 Translational Cancer Medicine COMPANION DIAGNOSTICS : The Potential Impact of Recently Approved and Emerging Molecular Diagnostics in Drug-Diagnostics Co-Development Francis Kalush
January 26, 2009 7th Annual Partnering with Central Labs Track C : Working Together to Develop Biomarkers for Safety Monitoring and Surrogate Endpoints Wendy Sanhai
September 29, 2008 Genomic Biomarkers Title to be Announced Alberto Gutierrez
June 18, 2008 Accelerating Anticancer Agent Development and Validation Workshop Faculty Richard Pazdur
Panel Discussion: Obstacles to Development--Ten Barriers to Proving Agents are Effective and Safe Joseph Gootenberg
FDA Drug INDs Haleh Saber
Panel Discussion Haleh Saber
Dinner Panel: "Major Oncology Topics in the Press" Richard Pazdur
Drug Registration Strategies Richard Pazdur
Panelists Richard Pazdur
May 30, 2008 ASCO Annual'08 Meeting cancer genetics-- Integration of Molecular Testing into Clinical Decision Making Steven Gutman
clinical trials-- Beyond RECIST: Meaningful and Acceptable Endpoints in Phase II Trials Robert L. Justice
tumor biology-- Integration of Molecular Testing into Clinical Decision Making Steven Gutman
March 25, 2008 Molecular Diagnostics Regulation of Diagnostic Tests Steven Gutman
March 25, 2008 PATHWAY ANALYSIS Pathway Tools in the Interpretation of Genomic Data in VXDS Federico Goodsaid
March 25, 2008 R&D Risk Mitigation Regulation of Diagnostic Tests Steven Gutman
March 25, 2008 Preclinical Development SDAR: Spectrometric Data Activity Relationship Modeling Dan Buzatu
March 25, 2008 CANCER MOLECULAR MARKERS Regulation of Diagnostic Tests Steven Gutman
March 25, 2008 TRENDS IN DRUG SAFETY SDAR: Spectrometric Data Activity Relationship Modeling Dan Buzatu
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.